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Abstract
Background: Cockayne syndrome is a rare autosomal recessive neurodegenerative disease characterized by low-
to-normal birth weight; growth failure; brain dysmyelination with calcium deposits, cutaneous photosensitivity;
pigmentary retinopathy, cataract, and sensorineural hearing loss. To the best of our knowledge, cholestatic liver
disease was not previously reported in these patients.
Aim: To highlight the presence of cholestasis and liver dysfunction in this group of patients and to suggest
modified criteria for clinical diagnosis.
Methods: The study included nine patients with Cockayne from four different families (five males and four
females) in which Cockayne was suspected clinically. In all patients chromosomal breakage studies revealed mild
(45%) to moderate (60%) increase in frequency of chromatid and chromosome gaps and breaks versus 25% in
normal controls. Diagnosis was confirmed by DNA repair assay.
Results: During routine follow up of these patients, seven of them had evident liver affection ranging from mild
elevation in liver enzymes to cholestatic liver disease and liver cell failure. The attacks were recurrent in two
patients and were sometimes preceded by infection. The attack may lead to deterioration of neurological and/or
liver condition. It may end in liver cell failure that either recovers completely or may lead to death.
Conclusions: liver disease could be considered common in Egyptian patients with Cockayne with the cholestatic
form being the most evident. The syndrome should be included in the list of causes of cholestatic liver disease.
Chromosomal breakage study and positive family history should be included as major criteria for clinical diagnosis
of Cockayne especially in a population like ours where consanguineous marriage is very high and molecular testing
and UV sensitivity tests are considered unaffordable.
Background
Cockayne syndrome (CS) was first reported in 1936 in
two siblings who were normal at birth but showed pro-
gressive mental retardation and had characteristic senile
facies with closely spaced sunken eyes. The disease is
characterized clinically by cachectic dwarfism, cutaneous
photosensitivity, loss of adipose tissue, mental retarda-
tion, skeletal and neurological abnormalities, pigmentary
degeneration of the retina and hepatomegaly [1]. Before
the molecular genetics of CS was understood, it was
thought that CS has a single, discrete phenotype: classic
CS. Now it is recognized that this syndrome spans a
spectrum that includes: CS type I (the classic form of
CS), type II, a more severe form with symptoms present
at birth (previously called cerebro-oculo-facial syndrome
(COFS) and Pena-Shokeir type II syndrome); CS type
III, a milder form; and xeroderma pigmentosum- Cock-
ayne syndrome (XP-CS) [2]. To the best of our knowl-
edge, cholestatic liver disease was not previously
reported in these patients.
Definitive diagnosis of CS can be done by DNA repair
assay [3] or molecular testing [4], both are expensive
and done in few specialized laboratory worldwide.
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The aim of this report is to highlight the presence of
cholestasis in this group of patients and to suggest mod-
ified criteria for clinical diagnosis.
Methods
1- Patients and families
Family (1)
Patient (1) is a 3 years old female, the second in order
of birth of a first cousin marriage (Figures 1 and 2). She
was referred to the genetic clinic at the age of one year
with a provisional diagnosis of congenital Rubella syn-
drome. At presentation she had jaundice of one week
duration, her length was 71.5 cm (less than - 4 SD),
weight was 7 Kg (less than - 4 SD), and skull circumfer-
ence was 39 cm (microcephalic). She had global devel-
opmental delay (that progressed in the next years),
enophthalmia with characteristic physical appearance
and cutaneous photosensitivity. Abdominal examination
revealed an enlarged liver (8 cm below the costal mar-
gin) firm in consistency, with rounded border and
smooth surface. She had moderate ascites with bilateral
shifting dullness and bilateral lower limb oedema.
ALT was 94 IU/L (normal: 37), AST: 143 IU/L (nor-
mal: 40), total bilirubin: 5.9 mg/dl, direct bilirubin:
5 mg/dl, albumin: 1.5 g/dl. Prothrombin time (PT) was
prolonged with INR: 1.7. Hepatitis A virus IgM, HBsAg,
HBcAb IgM, hepatitis C virus antibodies were negative;
CMV, EBV and rubella (IgG and IgM) were also nega-
tive. Plasma aminoacids revealed a mild elevation of
methionine: 1.3 mg/dl (normal < 0.8) and an elevation
of methionine/phenylalanine ratio: 1.41 (normal < 1.0).
Acylcarnitine profile was normal. Total galactose (galac-
tose and galactose 1- phosphate combined): 1.7 mg/dl
(normal <15). Galactose 1- phosphate uridyle transferase
was: 71.2 uM (normal >60). DNA testing for galactose-
mia mutation revealed no copies of the Q188r, S135L,
K285N, or L195P (classical galactosemia) or N314D
(Duarte galactosemia).
Slit lamp examination revealed clear corneas and lens.
Fundus examination showed pigments around the disc
(bilateral retinal dystrophy). CT brain revealed central
and cortical involutional brain changes. MRI brain
revealed mild prominence of the brain sulci, fissures and
basal cisterns with mildly dilated ventricular system
more appreciated at the cerebellar hemispheres with
mildly prominent cerebellar fissures. This is in addition
to evidence of dysmyelinating process in the form of
periventricular hyperintensity. Nerve conduction velocity
and EMG showed normal studies.
The patient received ursodeoxycholic acid (UDCA) at
a dose of 20 mg/kg/day, vitamin E (100 mg/day), aldac-
tone (2 mg/kg/day), vitamin K (10 mg/day) and albumin
transfusion. She gradually improved over one month
and was discharged from the hospital on aldactone
(12.5 mg/12 hrs) and vitamin K (10 mg once daily). Her
investigations on discharge were: total bilirubin: 3.6 mg/
dl, direct bilirubin: 2.1 mg/dl, albumin: 4 g/dl, AST: 54
IU/L, ALT: 100 IU/L, and normal PT. After 2 months,
the amino acid profile was repeated and revealed normal
results. At that time, all drugs were stopped and after 6
months the liver condition was completely normal with
the mildly raised liver enzymes as the only abnormal
finding.
Patient (2) was the older brother of patient (1). He
died after a prolonged attack of jaundice at the age of
2 years before patient (1) presented to our clinic. Accord-
ing to the parents’ history and the available reports, the
patient had growth failure, similar characteristic features
to his sister, delayed physical and mental milestones,
microcephaly, cutaneous photosensitivity and cataract.
Fundus examination showed pigmentary retinopathy.
Family (2)
Patient (3) is a 4 years old boy, the third in order of
birth of first cousin marriage. He presented to the hepa-
tology clinic with jaundice following an attack of vomit-
ing and diarrhea. He had a similar attack at the age of
two years that regressed spontaneously.
On examination the patient had progressive neurolo-
gic dysfunction, his height was 95 cm (-2 SD), weight
was 13 kg (-3 SD) and skull circumference was 43 cm.
He had characteristic physical appearance with
enophthalmia, nystagmus, jaundice, and skin photosensi-
tivity. His liver was 4 cm below the costal margin, firm
Figure 1 Anteropesterior view of three patients in the studied
group.
Figure 2 Family pedigrees of the studied group.
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in consistency with rounded border and smooth surface.
The spleen was felt two cm below the costal margin.
Neurological examination showed intention tremors,
cerebellar ataxia, lost knee and preserved ankle deep
reflexes. Chest and heart examination were clinically
free.
Investigations at that time revealed ALT: 270 IU/L
(N: 37), AST: 232 IU/L (N: 40) GGT: 183 (N: 50), total
bilirubin: 3.35 mg/dl, direct bilirubin: 2.6 mg/dl, albu-
min: 3.2 g/dl, PT 11.7 sec. (INR: 1). Tests for HBV,
HCV, and HAV revealed negative results. Ceruloplasmin
level, protein electrophoresis and auto antibodies were
also normal.
Abdominal ultrasonography revealed enlarged liver
with regular border, homogenous echopatteren, patent
portal and hepatic veins. Fundus examination showed
no abnormality. CT brain was normal, while MRI brain
showed deep white matter signal alteration at the for-
ceps minor and major regions, middle cerebellar pedun-
cles, the posterior segmental aspects of the pontine
isthmus and basis pontis. Those areas exhibited bright
signal on FLAIR and T2W1, a picture consistent with
dysmyelinating disease.
The patient received ursodeoxycholic acid at a dose of
20 mg/kg/day and vitamin E (100 mg/day). Two months
later, ALT decreased to 83 IU/L, AST decreased to
95 IU/L, total bilirubin was: 1.7 mg/dl, direct bilirubin:
0.7 mg/dl, albumin: 3.2 g/dl, and PT 11.3 seconds.
Six months later, the patient had another similar
attack that was also precipitated by viral infection and
was associated with increased tremors, ataxia and inabil-
ity to walk. He received the same treatment with excel-
lent response and complete recovery of liver functions,
and improvement of ataxia, and tremors.
Patient (4) is a 13 years old boy (the older brother of
patient (3)). His weight was 17.5 kg (less than - 4 SD),
height was 115.5 cm (less than - 4 SD) and skull cir-
cumference was 50.5 cm. He had progressive neurologic
dysfunction, characteristic physical appearance of the
stooped standing appearance and senile facies, sunken
eyes and skin photosensitivity. Neurological examination
revealed typical cerebellar ataxia. He also had history of
recurrent attacks of jaundice before his presentation to
our clinic that were always preceded by infection. Biliru-
bin level, ALT, AST, INR and albumin were normal at
time of presentation. Urine and plasma aminograms
were also normal.
Family (3)
Patient (5) is a one month old boy, the second in order
of birth of first cousin marriage. He presented to the
genetics clinic with microcephaly (skull circumference:
31 cm), small anterior fontanel, deep seated eyes, poly-
dactyly of both hands and left foot. CT brain was nor-
mal. His older sister Patient (6): According to the
parents’ history and the medical reports, she had pro-
gressive neurological dysfunction, skin photosensitivity,
microcephaly, enophthalmos, nystagmus, cataract, and
spasticity of both lower limbs. Fundus examination
revealed pigmentary retinopathy and CT brain showed
calcification of basal ganglia. She developed jaundice
after anaesthesia for cataract extraction at the age of
10 years and died soon after the operation as a result of
hepatocellular failure.
Family (4)
Patient (7) is a 16 year old girl, the second in order of
birth of first cousin marriage. She presented to the
genetics clinic with severe growth retardation, progres-
sive intellectual deterioration, deep seated eyes, bilateral
cataract, and cerebellar ataxia. Her weight was 12.5 Kg
(< 4SD), length was 120 cm (she could not stand), and
skull circumference was 49.8 cm. Her abdominal exami-
nation revealed no organomegaly but her ALT was
mildly elevated (46 IU/L, normal: 40). Nerve conduction
velocity showed axonal neuropathic disease and audio-
metry showed moderate sensorineural hearing loss.
Patient (8): is a 6 year old boy, the brother of patient
(7). His height was 110 cm (< 4SD), his weight was
11.5 Kg (< 4SD) and skull circumference was 44 cm. He
had the same characteristic physical features of his older
sister with cataract and cerebellar ataxia. Abdominal
examination revealed enlarged liver (palpable 4 cm
below the costal margin). His chest and heart examina-
tion were clinically free.
Abdominal ultrasound showed mildly enlarged liver
with normal spleen. ALT was 135 IU/L (normal = 40),
AST was 126 IU/L (normal = 37) and GGT was 85 U/L
(normal = 50). Nerve conduction velocity showed axonal
neuropathic disease and audiometery showed moderate
sensorineural hearing loss.
Patient (9): is a 2.5 year old girl, the youngest sister of
patient (7 and 8). Her height was 90 cm and her weight
was 8.5 Kg and skull circumference was 42 cm. She had
bilateral cataract that was extracted at the age of 1.5
years and cerebellar ataxia. Abdominal examination
revealed mildly enlarged liver which was palpable 2 cm
below the costal margin. Her chest and heart examina-
tion were clinically free. Abdominal ultrasound showed
no abnormalities apart from the mildly enlarged liver.
ALT was 101 IU/L (normal = 40), AST was 49 IU/L
(normal = 37) and GGT was 27 U/L (normal = 50).
Although bilirubin level in this family was normal, GGT
was mildly increased in patient (8). Table 1 and 2
demonstrates patient clinical criteria and laboratory
investigations at time of presentation.
2- Chromosomal breakage studies
All cases were subjected to both routine phytohemag-
glutinin stimulated peripheral blood cultures and
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chromosomal breakage study using mitomycin C and
diepoxybutane independently according to previously
described methods [5]. Karyotype was done from rou-
tine cultures to exclude constitutional rearrangements
and to detect any spontaneous breakage. Harvesting and
analysis of at least 20 metaphases from breakage induc-
tion cultures and scoring of numbers and types of
induced chromosomal aberrations was also done. All
metaphases from routine culture revealed normal karyo-
type excluding constitutional abnormalities. Chromoso-
mal breakage studies revealed mild (45%) to moderate
(60%) increase in frequency of chromatid and chromo-
some gaps and breaks versus 25% in normal control
(Figure 3)
3- DNA recovery tests
DNA recovery tests were done to one patient in each
family (patient number 1, 3, 5 and 7). In this test cul-
tured fibroblasts were labeled with 14C thymidine to
have a measure for the amount of cells in the dish (thy-
midine is a measure of DNA synthesis). Then the cells
were irradiated with UV light and incubated further in
fresh medium. Three UV doses were used (1, 3 and 6J/
m2). After 17 hours, the incorporation of thymidine into
the DNA was measured again. In normal cells DNA
synthesis decreases strongly in the first few hours after
UV but the rate begins to increase again after 3-6 hours
and keeps recovering during the next 24 hours
Table 1 Patient criteria according to Nancy and Berry 1992 [2]
Clinical criteria 1 2 3 4 7 8 9
Major criteria Post natal growth failure + + + + + + +
Progressive neurological dysfunction + + + + + + +
Minor criteria Cutaneous photosensitivity + + + + - - -
Peripheral neuropathy - ND ND ND + + ND
Pigmentary retinopathy and/or cataract + + _ - + + +
SNHL ND ? ND ND + + ND
Dental caries + ? + + + + +
Characteristic physical appearance + + + + + + +
Family history + + + + + + +
Patients 5 and 6 were excluded as the criteria do not apply to them (CS type II). ND: not done, SNHL: sensorineural hearing loss.
Table 2 Clinical and laboratory data of patients at
presentation
Patient No. 1 2 3 4 5 6 7 8 9
Age (years) 3 2 4 13 0.8 10 16 6 2.5
Sex F M M M M F F M F
Jaundice + + + - - + - - -
Hepatomegaly + NAD + - - NAD - + +
splenomegaly - NAD + - - NAD - - -
Ascites + NAD - - - NAD - - -
Total bilirubin (mg/dl) 5.9 NAD 3.35 N N NAD N N N
Direct (mg/dl) 5 NAD 2.6 N N NAD N N N
ALT(XN) 2.5 NAD 7.2 N N NAD 1.15 3.4 2.5
AST (XN) 3.5 NAD 5.8 N N NAD 0.7 1.7 1.3
GGT (U/L) 128 NAD 183 N ND NAD 30 85 50
Albumin (gm/dl) 1.5 NAD 3.2 N N NAD N N N
INR 1.7 NAD 1 N N NAD N N N
M: male, F: female, +: present, -: absent, NAD: No available data, N: normal,
ND: Not done.
Figure 3 Metaphase spread showing increase in frequency of
chromatid and chromosome gaps and breaks in our patients
with CS.
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(depending on the dose). In CS cells DNA synthesis is
strongly inhibited and does not recover at all.
In this study, cells from the four patients showed
strongly reduced recovery of DNA synthesis after UV
radiation, confirming the diagnosis of Cockayne syn-
drome (table 3, Figure 4)
Results and Discussion
Liver dysfunction was a prominent feature in our group
of patients with CS (7/9 (77.8%)). Although they mani-
fested different forms of liver affection, the most evident
were hepatomegaly and recurrent attacks of cholestasis.
To best of our knowledge, cholestatic liver disease was
not described before although hepatomegaly and hepatic
dysfunction as a complication of anesthesia were pre-
viously reported [6].
It was observed that our patients’ attacks were pre-
ceded (or precipitated) by infection (patient 3 and 4), a
stressful conditions (surgery) or by a possible hepato-
toxic drug that was used during anesthesia (patient 6).
These attacks led to deterioration of the patient’s liver
condition and were associated with worsening of their
neurological symptoms. In patient 3 and 4, the jaundice
was followed by inability to walk or increased tremors
and ataxia. It proceeded to liver cell failure that had
recovered completely (patient 1), or ended in death as
in (patients 2 and 6).
Although these attacks may have resolved sponta-
neously, vitamin E and UDCA were given to hasten
their resolution and preserve the liver condition. Several
mechanisms have been proposed to explain the potential
beneficial effects of UDCA in the treatment of chole-
static liver disease. Because intracellular retention of
hydrophobic bile acids is thought to injure liver cells,
replacement of these compounds with a nontoxic hydro-
philic bile acid such as UDCA should theoretically
reduce injury. UDCA may be hepatoprotective by displa-
cing toxic bile acids from both the bile acid pool and
hepatocellular membrane [7].
The major function of vitamin E is its role as an anti-
oxidant, protecting cell membrane polysaturated fatty
acids and thiol-rich proteins from oxidant damage
initiated by free-radical reactions [8]. As vitamin E defi-
ciency may impair immune function and may worsen
cholestatic liver injury [9], it was used in our patients
with CS and cholestasis.
Considering the high consanguinity rate in our popu-
lation, the presence of another recessive entity causing
liver diseases in these patients would make sense espe-
cially that it was previously reported by our group [10].
The presence of cholestatic liver disease in 4 different
families from 4 different regions in Egypt support that
liver affection is a feature of CS and contradicts the
above assumption.
Despite the various diagnostic tests, early diagnosis for
CS is still problematic. This was obvious in all reported
patients in this study (congenital Rubella syndrome in
family (1), unidentified liver disease in family (2), and
unknown genetic disease in families (3, 4)).
Clinical diagnostic criteria for CS type I were sug-
gested by Nance and Berry, 1992 [2]. Seven of the
patients were CS type I (they met these criteria) and
two (patients 5 and 6) were CS type II. The diagnosis
was highly suspected in the presence of an affected sib
and by the presence of mild to moderate increase in
chromosomal breakage using mitomycin C in all
patients. This is in contrast to patients with Fanconi
anemia where a very high breakage (90-100%) with a
very significant level of exchange and asymmetrical
interchange is usually noted (Figure 5).
Table 3 Strongly reduced recovery of DNA synthesis after
3J/m2 of UV-irradiation in patients with CS compared to
positive controls (known CS patients) and negative
controls (normal individuals)
Patients % of Recovery of DNA synthesis at 17 hrs after
UV (3J/m2)
Our patients Known CS patients Normal controls
Patient (1) 13 14 80
Patient (3) 13 15 88
Patient (5) 15 22 74
Patient (7) 24 26 67
It can be noticed that normal cells can recover 67 to 88% of DNA compared
to only 13-24% in patients with CS.
Figure 4 Response of cells from patients to different doses of
UV irradiation compared to controls. There is strongly reduced
recovery of DNA synthesis after UV-irradiation in our patients
compared to the normal control.
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Therefore, we suggest that the diagnostic criteria
should be modified to include chromosomal breakage
study (which is a simple inexpensive test) as a major cri-
terion especially in very young patients in whom the
diagnosis is extremely difficult and in a poor country
like ours in which the DNA repair studies and molecu-
lar studies are extremely expensive. Also it should
include positive family history especially in populations
with high prevalence of consanguineous marriage like
ours (35-50%) in which the affection of more than one
member in the family is quite common [11]. This may
be further supported by the variability in the clinical
presentation even between members of the same family
(table 1) which was previously reported by Pasquier
et al, 2006 [12].
Conclusions
Liver disease could be considered common in Egyptian
patients with CS with the cholestatic form being the
most evident. Stressful condition may precipitate these
attacks and liver support with careful follow up is extre-
mely essential during the attacks, together with avoid-
ance of hepatotoxic drugs. Further studies on a larger
number of patients are needed to investigate whether
these observations are part of CS or a simple association
in these extremely cachectic patients.
We suggest that the diagnostic criteria of CS should
be modified to include chromosomal breakage study
(which is a simple inexpensive test) and positive family
history as major criteria especially in very young patients
in which the diagnosis is extremely difficult and in a
poor country like ours in which the DNA repair studies
and molecular studies are extremely expensive.
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